Skip to main content

ADA Activity and dATP Levels in Erythrocytes after Bone Marrow Transplantation

  • Chapter
Purine and Pyrimidine Metabolism in Man X

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 486))

Conclusion

The immediate decrease in red cell dATP and increase in ADA activity post BMT, correlates with the contribution of the non-engrafted donor haematopoietic cells to clearing circulating dAdo by providing functional ADA activity. It has been established that erythrocyte precursors are not normally engrafted. Consequently, as these cells reach the end of their life span their contribution falls and a steady state is attained with red cell ADA falling to almost undetectable levels accompanied by a slight rise in dATP.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Simmonds HA, Panayi GS, Corrigall V. A role for purine metabolism in the immune response: Adenosine deaminase activity and deoxyadenosine catabolism. Lancet 1978; 1: 60–63.

    CAS  PubMed  Google Scholar 

  2. Hershfield MS, Mitchell BS. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiencies. Chapter 52. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill, 7th edition: 1995; 1725–1768.

    Google Scholar 

  3. Shovlin CL, Simmonds HA, Fairbanks LD, Deacock S, Hughes JMB, Lechler RI, Webster ADB, Sun Xio-Ming, Webb JC, Soutar AK. Adult onset immunodeficiency due to adenosine deaminase deficiency. J Immunol 1994; 153: 2331–2339.

    CAS  PubMed  Google Scholar 

  4. Fischer A, Landais P, Friedrich W, Morgan G, Gerritsen B, Fasth, A et al. European experience of bone-marrow transplantation for severe combined immunodeficiency. Lancet. 1990; 336: 850–854.

    Article  CAS  PubMed  Google Scholar 

  5. Simmonds HA, Duley JA, Fairbanks LD, Marinaki AM. Genetic disorders of purine and pyrimidine metabolism: Problems of diagnosis. CPD Bulletin Clin Biochem 2000; 2: 13–19.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Fairbanks, L.D., Simmonds, H.A., Duley, J.A., Gaspar, H.B., Flood, T., Steward, C.A. (2002). ADA Activity and dATP Levels in Erythrocytes after Bone Marrow Transplantation. In: Zoref-Shani, E., Sperling, O. (eds) Purine and Pyrimidine Metabolism in Man X. Advances in Experimental Medicine and Biology, vol 486. Springer, Boston, MA. https://doi.org/10.1007/0-306-46843-3_10

Download citation

  • DOI: https://doi.org/10.1007/0-306-46843-3_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46515-4

  • Online ISBN: 978-0-306-46843-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics